The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent.
Scattered data suggested that disodium cromolyn, well known as a mast cell stabilizer shows some effects on tumor cells and tumor-associated newly formed vascular networks. Most of these studies used tumor cell lines assessed by in vitro studies. Nor disodium cromolyn effects on melanoma cell lines were studied yet, neither its influence on recruited tumor blood vessels or angiogenic growth factors expression. We designed here a study regarding disodium cromolyn effects on A375 melanoma tumor cells implanted on chick embryo chorioallantoic membrane (CAM) and on blood vessels recruited by the experimental melanoma in the absence of mast cells, knowing that within CAM, the existence of mast cells are not certified yet. We also assessed the role of disodium cromolyn on the expression of several angiogenic growth factors. Disodium cromoglycate differentially acts on tumor cells and blood vessels. Extensive necrotic areas of experimental melanoma together with an increased number of peritumor blood vessels were observed in treated specimens as compared with untreated tumors. Disodium cromolyn inhibited VEGF and PDGF-BB expression, and had no effects on EG VEGF expression between treated and non treated specimens in a mast cells free microenvironment. Our results sustain the direct antitumor effects of sodium cromolyn and suggest the involvement of several growth factors in the recruitment of tumor vessels by A375 melanoma tumor cells. The expression of growth factors is differentially influenced by sodium cromolyn treatment.
Department of Microscopic Morphology/Histology, Angiogenesis Research Center, "Victor Babes" University of Medicine and Pharmacy, Pta Eftimie Murgu 2, Timisoara, 300041, Romania. ancacimpean1972@yahoo.com.
Anca Maria
AM
Cimpean
Department of Microscopic Morphology/Histology, Angiogenesis Research Center, "Victor Babes" University of Medicine and Pharmacy, Pta Eftimie Murgu 2, Timisoara, 300041, Romania.
Marius
M
Raica
D043925:Angiogenesis Inducing Agents / Q000737:chemistry*; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000737:chemistry; D000970:Antineoplastic Agents / Q000276:immunology*; D000077214:Becaplermin; D001808:Blood Vessels / Q000276:immunology; D045744:Cell Line, Tumor; D002642:Chick Embryo; D049033:Chorioallantoic Membrane / Q000276:immunology*; D004205:Cromolyn Sodium / Q000737:chemistry*; D005260:Female; D006801:Humans; D008407:Mast Cells / Q000166:cytology / Q000187:drug effects* / Q000276:immunology*; D008545:Melanoma / Q000276:immunology; D008875:Middle Aged; D009336:Necrosis; D009389:Neovascularization, Pathologic; D020574:Proto-Oncogene Proteins c-sis / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D043925:Angiogenesis Inducing Agents; D018927:Anti-Asthmatic Agents; D000970:Antineoplastic Agents; D020574:Proto-Oncogene Proteins c-sis; D042461:Vascular Endothelial Growth Factor A; D000077214:Becaplermin; D004205:Cromolyn Sodium
Blood vessels; Chorioallantoic membrane; Sodium cromolyn; Tumor cells